ProSensa Holding N.V. (RNA) Strengthens Its Management Team And Supervisory Board With Key Appointments
6/30/2014 7:43:57 AM
Leiden, The Netherlands, June 30, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, today announced the appointment of Willem W. van Weperen to the new position of chief commercial officer and the addition of Dr. Annalisa Jenkins to its Supervisory Board.
Help employers find you! Check out all the jobs and post your resume.
comments powered by